These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32622008)

  • 21. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
    d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
    Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
    [No Abstract]   [Full Text] [Related]  

  • 22. The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
    Malviya A
    Int J Infect Dis; 2020 Oct; 99():310-311. PubMed ID: 32738490
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
    Funck-Brentano C; Salem JE; Nguyen LS; Drici MD; Roden DM
    Arch Cardiovasc Dis; 2020 May; 113(5):367-368. PubMed ID: 32331979
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
    Brito-Azevedo A
    Int J Infect Dis; 2020 Oct; 99():324. PubMed ID: 32768698
    [No Abstract]   [Full Text] [Related]  

  • 25. Risch Responds to "How to Consider Low Reported Death Rates in COVID-19".
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1230-1231. PubMed ID: 32685962
    [No Abstract]   [Full Text] [Related]  

  • 26. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
    Zampieri FG
    Ann Am Thorac Soc; 2020 Aug; 17(8):937-938. PubMed ID: 32735169
    [No Abstract]   [Full Text] [Related]  

  • 27. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
    Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
    Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 29. Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Miller MC; Abraham GM; Obley AJ; Forciea MA; Jokela JA; Humphrey LL;
    Ann Intern Med; 2020 Jul; 173(2):W48-W51. PubMed ID: 32551892
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
    Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
    Wiseman DM
    Int J Infect Dis; 2020 Oct; 99():344-345. PubMed ID: 32768694
    [No Abstract]   [Full Text] [Related]  

  • 32. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32862840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL
    Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
    Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
    JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
    Fleury V
    Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 38. An Ounce of Prevention and a Pound of Cure: Randomized Clinical Trials of Therapeutics Against COVID-19 and an Assessment of Personal Protective Equipment and Distancing.
    Sher DJ
    Int J Radiat Oncol Biol Phys; 2020 Oct; 108(2):333-336. PubMed ID: 32890500
    [No Abstract]   [Full Text] [Related]  

  • 39. RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS".
    Peiffer-Smadja N; Costagliola D
    Am J Epidemiol; 2020 Nov; 189(11):1443-1444. PubMed ID: 32685975
    [No Abstract]   [Full Text] [Related]  

  • 40. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
    Intson K; Kumar S; Botta A; Neckles R; Leung C; Jawaid A
    Swiss Med Wkly; 2020 Apr; 150():w20262. PubMed ID: 32347963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.